ClearArc Capital’s ResMed RMD Stock Holding History

ClearArc Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$238K	Sell	1,534 -645	-30%	-$93K	0.09%	256
2019 Q3	$294K	Buy	2,179 +57	+3%	+$7.47K	0.09%	269
2019 Q2	$259K	Sell	2,122 -272	-11%	-$30.1K	0.08%	291
2019 Q1	$249K	Sell	2,394 -52	-2%	-$5.37K	0.07%	315
2018 Q4	$279K	Sell	2,446 -1,260	-34%	-$135K	0.08%	263
2018 Q3	$427K	Buy	3,706 +83	+2%	+$9.09K	0.06%	307
2018 Q2	$375K	Sell	3,623 -24	-0.7%	-$2.43K	0.05%	330
2018 Q1	$359K	Buy	3,647 +19	+0.5%	+$1.79K	0.05%	342
2017 Q4	$307K	Sell	3,628 -48	-1%	-$3.97K	0.04%	388
2017 Q3	$283K	Buy	+3,676	New	+$281K	0.04%	390

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearArc Capital's RMD Position: Q4 2019 in Review

ClearArc Capital reduced its ResMed (RMD) stake by 30% in Q4 2019, selling an estimated $93K and leaving 1,534 shares worth $238K. The position accounts for 0.09% of the portfolio, ranked #256.

ClearArc Capital first reported a position in RMD in Q3 2017 and has held it in 10 quarters since. The position peaked at $427K in Q3 2018. 560 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

ClearArc Capital held 1,534 shares of ResMed worth $238K as of Q4 2019.
ClearArc Capital sold 645 ResMed shares in Q4 2019, an estimated $93K.
ResMed made up 0.09% of ClearArc Capital's portfolio in Q4 2019, its #256 holding.
ClearArc Capital first reported a position in ResMed in Q3 2017 and has held it in 10 quarters since.
ClearArc Capital's ResMed position peaked at $427K in Q3 2018.
560 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.